April 11, 2018 / 6:35 AM / 3 months ago

Alexion to buy Swedish biotech Wilson Therapeutics for $855 mln

April 11 (Reuters) - Alexion Pharmaceuticals said on Wednesday it had agreed to buy Sweden’s Wilson Therapeutics for 7.1 billion Swedish crowns ($855 million) to boost its line-up of rare disease drugs.

The U.S. group is acquiring the business through a tender offer worth 232 crowns per share.

$1 = 8.3000 Swedish crowns Reporting by Ben Hirschler; Editing by Susan Fenton

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below